AstraZeneca boss says firm has worked out 'winning formula' to boost Oxford vaccine's efficacy

Pascal Soriot, chief executive of the British-Swedish pharmaceutical firm, told the Sunday Times that a two-dose method can push the vaccine's efficacy rate towards that of its rivals.